首页> 外文期刊>Journal of Molecular Neuroscience: MN >Increased Expression of Protease-Activated Receptor 2 and 4 Within Dorsal Root Ganglia in a Rat Model of Bone Cancer Pain
【24h】

Increased Expression of Protease-Activated Receptor 2 and 4 Within Dorsal Root Ganglia in a Rat Model of Bone Cancer Pain

机译:骨癌痛大鼠模型中蛋白酶激活的受体2和4的表达在背根神经节内。

获取原文
获取原文并翻译 | 示例
           

摘要

In an effort to understand the underlying mechanisms of cancer-induced bone pain, we investigated the presence of two protease-activated receptors, protease-activated receptor 2 (PAR2), and protease-activated receptor 4 (PAR4), in dorsal root ganglia (DRGs) neurons in an animal model of bone cancer pain. Female Wistar rats were randomized into three groups: tumor-bearing animals killed after 14 days (D14) and tumor-bearing animals killed after 21 days (D21) group and a sham operation group. After establishment of the Walker 256 carcinoma bone cancer pain model, behavioral tests were carried out to determine both the spontaneous nocifensive behavior and the paw withdrawal threshold (PWT) of mechanical and thermal hyperalgesia in these rats. Subsequently, real-time RT-PCR, Western bolt, and immunofluorescence were used to determine the messenger RNA (mRNA) and protein expression of PAR2 and PAR4 in the ipsilateral lumbar 4-5 DRG neurons. Rats in the D21 treatment group displayed a significant increase in spontaneous nocifensive behavior scores compared with the sham group as well as a considerably decreased withdrawal threshold in mechanical allodynia and thermal stimulation. Compared to sham group, the relative mRNA and protein expression of PAR2 and PAR4 was significantly upregulated in the D14 group and D21 groups, concurrent with tumor growth and proliferation. In addition, we identified the co-expression of PAR2 and PAR4 in the DRG neurons. The upregulation of mRNA and protein levels as well as the co-localization of PAR2 and PAR4 in DRG neurons suggests their novel involvement in the development and maintenance of bone cancer pain.
机译:为了了解癌症引起的骨痛的潜在机制,我们研究了背根神经节中两种蛋白酶激活受体蛋白酶激活受体2(PAR2)和蛋白酶激活受体4(PAR4)的存在(骨癌疼痛动物模型中的DRG)神经元。将雌性Wistar大鼠随机分为三组:第14天(D14)后处死的荷瘤动物和第21天(D21)后处死的荷瘤动物组和假手术组。建立Walker 256癌骨癌疼痛模型后,进行了行为测试,以确定这些大鼠的机械和热痛觉过敏的自发伤害行为和爪缩回阈(PWT)。随后,使用实时RT-PCR,Western bolt和免疫荧光法确定同侧腰4-5 DRG神经元中PAR2和PAR4的信使RNA(mRNA)和蛋白表达。与假手术组相比,D21治疗组的大鼠自发伤害行为得分显着提高,机械异常性疼痛和热刺激的戒断阈值明显降低。与假手术组相比,D14和D21组PAR2和PAR4的相对mRNA和蛋白表达显着上调,并伴有肿瘤的生长和增殖。此外,我们确定了DRG神经元中PAR2和PAR4的共表达。在DRG神经元中,mRNA和蛋白水平的上调以及PAR2和PAR4的共定位表明它们在骨癌疼痛的发展和维持中具有新颖性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号